Clinical trial
A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency
NCT00400842 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00400842 |
|---|---|
| Title | A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency |
| Official title | A Double-blind, Placebo-controlled, Parallel-group, Comparative Study to Confirm the Safety and Efficacy of Oral 1.5 g/Day and 3.0 g/Day of SA-001 in Patients With Pancreatic Exocrine Insufficiency Caused by Chronic Pancreatitis or by Pancreatectomy |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Exocrine Pancreatic Insufficiency, Chronic Pancreatitis |
| Intervention type | Drug |
| Interventions | SA-001, Placebo |
| Enrollment | 274 |
| Start date | May 1, 2007 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Nov 17, 2006 |
| Last update posted | Jul 28, 2011 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: